The effect of psyllium oral supplementation on insulin resistance and lipid profile in non diabetic patients with polycystic ovary syndrome
- Conditions
- polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT2016091929508N4
- Lead Sponsor
- Vice chancellor for research, Urmia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 54
Age range 18-45 years; PCOs diagnosis based on the Rotterdam; Persons with fasting glucose concentrations in the range of less than 126 mg /dl; Exclusion criteria: Smoker or addict; Individuals receiving glucose-lowering drugs other than Metformin; Corticosteroid consumer; Consumer drugs such as Lithium, Carbamazepine and Digoxin; Warfarin consumer; Individuals with a history of Myocardial Infarction, Kidney, Liver and Lung diseases; Individuals with Thyroid Dysfunction; Individuals with major surgery in the last 6 months; Individuals with a history of allergy to Psyllium and Aspartame; Patients with Phenylketonuria; Patients with type 1 diabetes, Gastrectomy and Parkinson's disease; Individuals with a history of Gastrointestinal Disease, particularly persistent constipation and narrowing and blockage of the intestinal tract; Individuals treated with drugs that affect blood lipid profile; Individuals with a history of diseases such as Congenital Adrenal Hyperplasia, Cushing's syndrome, Hyperprolactinemia, the androgen-secreting tumors and Thyroid disease; Patients treated with antidepressant medications and recent treatment for eating disorder; Individuals treated with other fiber supplements.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method